High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$18.0M
$17,972,698
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
VRCA
P
Verrica Pharmaceuticals Inc.
Manning Paul B
• Director
Discretionary BuyΔOwn +53.2%
2025-11-25
$5,835,050Whale
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
Director
Discretionary BuyΔOwn +53.2%
|
2025-11-25 | $5,835,050Whale | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Manning Paul B
• Director
Discretionary BuyΔOwn +460.3%
2025-11-25
$11,670,108MEGA
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
Director
Discretionary BuyΔOwn +460.3%
|
2025-11-25 | $11,670,108MEGA | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Kirby John J.
• CFO
Discretionary BuyΔOwn +65.2%
2025-11-25
$15,001
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
CFO
Discretionary BuyΔOwn +65.2%
|
2025-11-25 | $15,001 | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Rosenberg Noah L.
• Officer • CMO
Discretionary Buy
2025-11-25
$10,000
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
Officer • CMO
Discretionary Buy
|
2025-11-25 | $10,000 | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Rieger Jayson
• CEO
Discretionary BuyΔOwn +106.8%
2025-11-25
$400,114
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
CEO
Discretionary BuyΔOwn +106.8%
|
2025-11-25 | $400,114 | P | Form 4 |
|
VRCA
P
Verrica Pharmaceuticals Inc.
Zawitz David
• COO
Discretionary BuyΔOwn +90.9%
2025-11-25
$42,425
|
||||||
| VRCA |
Verrica Pharmaceuticals Inc.
|
COO
Discretionary BuyΔOwn +90.9%
|
2025-11-25 | $42,425 | P | Form 4 |